Skip to content
Screener

Pediatrix Medical Group MD Q1 2026 earnings

Reported May 5, 2026 · Before market open

Revenue$476.2MBeat by $10.4M
EPS$0.44Beat by $0.07
Revenue estimate$465.8M
EPS estimate$0.37

Next report

Nov 2, 2026 (In 2 weeks)
Revenue estimate$498.2M
EPS estimate$0.65

Financials

Q1 2026

Income statement

See full
Revenue$476.2M+3.9%
Operating income$41.7M+29.8%
Net income$29.6M+42.6%
EPS (diluted)$0.36+50.0%

Balance sheet

See full
Cash & equivalents$205.8M+108%
Total debt$629.7M-3.9%
Total equity$878.6M+11.3%
Total assets$2.1B+3.9%

Cash flow

See full
Operating cash flow-$129.8M-10.5%
CapEx$6.2M+88.3%
Free cash flow-$136.1M-12.7%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$1.78B+42.9%
Enterprise value$2.2B+22.3%
P/E10.2×—
P/S0.9×+0.3×

Profitability

See full
Operating margin11.3%—
Net margin9%—
FCF margin12.3%+2.5pp

Returns & leverage

See full
Return on equity20.9%—
Debt / equity0.7×-0.1×
Current ratio1.3×-0.5×

Segments

By product

See full
Health Care Patient Service$405.4M+4.1%
Hospitals Contracts$69.9M+7.3%

FAQ

When did Pediatrix Medical Group report Q1 2026 earnings?
Pediatrix Medical Group (MD) reported Q1 2026 earnings on May 5, 2026 before market open.
What were Pediatrix Medical Group's Q1 2026 revenue and EPS?
Pediatrix Medical Group reported revenue of $476.2M and eps of $0.44 for Q1 2026.
Did Pediatrix Medical Group beat estimates in Q1 2026?
Revenue beat the consensus estimate of $465.8M by $10.4M. EPS beat the consensus estimate of $0.37 by $0.07.
How did Pediatrix Medical Group's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 3.9% from $458.4M a year earlier and eps grew 33.3% from $0.33.
Where can I find Pediatrix Medical Group's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-204982) and the 10-Q periodic report (0001193125-26-204993) directly on SEC EDGAR. The filing index links above go to sec.gov.